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RapidPlan software in generating clinically acceptable plans 
in a semi-automated manner for 5-field IMRT prostate 
treatments. Statistical guidance on exclusion of outliers 
appears somewhat conservative – inclusion of all available 
good quality plans should improve the scope and robustness 
of the model.  
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Purpose/Objective: The aim of this study is to evaluate the 
geometric performances of the treatment planning system 
(TPS) in external radiotherapy in order to identify its limits. 
Materials and Methods: Eclipse (Version 10) TPS was 
evaluated with the quality control software Digibox (version 
2.2). Digibox has a control points database, in which the 
operator selects some to create a set of control points that 
will be identified as a new quality control. For each control 
point of the quality control, Digibox prepares a digital test 
object (DTO) that automatically transfer to the TPS via the 
network. The operator then performs on the TPS the 
geometrical operation he wants to test. The test result is 
then returned to Digibox that analyses by comparing it with a 
theoretical result DTO. This study is composed of two 
sections. Section 1 deals with the beams display. Section 2 is 
about the definition of contours, margins, isocenter and the 
beams conformation. 
Results: 152 elementary geometrical operations were 
performed for a period of 14 hours of work, not included 
import and export times. The results of section 1 show no 
significant difference. The tests were: rotation of the 
collimator, beam angles, filed sizes and beam divergence. 
The results of section 2 showed however some important 
differences, especially on 3D margins for volumes with 
variable sections and small structures (<12 cm3), and the 
automatic positioning of the isocenter in complex structures. 
Minor discrepancies were identified on the conformation of 
the beams and jaws, the automatic contouring, and 
calculation of the volume of a structure showed less 
variation. 
Conclusions: Using Digibox, we could highlight two types of 
problems which one particularly concerns the stereotactic 
technique. This digital evaluation is an asset and can be used 
when an upgrade of the TPS is performed or to compare the 
performances of two TPS in the same department. Finally, 
the study of the definition of the bolus, the blocks, the 
distances calculation and the zoom tool are not yet possible 
with Digibox. 
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Purpose/Objective: To evaluate the performance of a 
knowledge-based DVH estimation constraints, namely 
RapidPlan, for optimising volumetric modulated arc therapy 
(RapidArc) applied to advanced lung cancer and to low risk 
prostate carcinoma patients.  
Materials and Methods: Two sets, one for lung and one for 
prostate cases, each of 27 previously treated patients, were 
selected to configure and train models for the estimation of 
dose-volume constraints to use in the optimization process. 
The models were subsequently validated on the same sets of 
27 plans each (closed-loop) and on further two sets each of 
25 patients not used for the training (open-loop). The two 
site groups differ mainly in the homogeneity of the 
characteristics: 
- Advanced lung cancer group: in-homogeneous dose 
prescription (50-70 Gy), wide variety of target volumes (67-
1193 cm3), two partial arc geometry 
- Low risk prostate group: homogeneous dose prescription (78 
Gy), modest variability of target volumes (80-421 cm3), single 
full arc geometry 
Analysis was based on DVH and statistics comparison between 
the RapidPlan and the original clinically accepted plans. 
Second endpoint was the evaluation of the pass-fail analysis 
for the two groups of plans based on consolidated criteria as 
following. For lung cases: D99%>95%(90%) and D1%<107% for 
CTV(PTV); mean<20Gy for ipsilateral, mean<15Gy and 
V20Gy<20% for contralateral lung; D1cm3<45Gy to spine; 
V45Gy<30% and V50Gy<20% for heart; D1cm3<70Gy and V30Gy<30% 
for oesophagus. For prostate cases: D99%>95% and D1%<107% for 
PTV; V70Gy<10%, V60Gy<40% and V50Gy<50% for rectum; V70Gy<30% 
and V60Gy<50% for bladder; Dmax<50Gy for femoral heads. 
Results: Average differences between the RapidPlan and the 
original plans of some dosimetric values are reported in the 
table (p values in parenthesis), where negative values 
indicate a superior mean plan quality of RapidPlan (the 
opposite for D99% for target). A significant improvement is 
shown for RapidPlan plans in both closed- and open-loop 
validations. 
 
 
 
In the pass-fail analysis, the rate of criteria not fulfilled was 
reduced in the lung patients group from 11% to 7% in the 
closed-loop and from 13% to 10% in the open-loop studies; in 
the prostate patients group it was reduced from 4% to 3% in 
the open-loop study. 
Conclusions: Plans were optimised using a knowledge-based 
model showed dosimetric improvements when compared to 
the original benchmark data, particularly in the sparing of 
organs at risk. The data suggests that the new engine is 
